Century Therapeutics, Inc. (IPSC) vs Surrozen, Inc. (SRZN)

Century Therapeutics, Inc. and Surrozen, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Surrozen, Inc. are of similar size ($294.7M and $271.6M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −8.79%. Century Therapeutics, Inc. has the higher net margin (0.00% vs −2,887.1%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 14 metrics below, Century Therapeutics, Inc. leads on 9 and Surrozen, Inc. on 5.

Valuation

Metric IPSC SRZN Biotechnology median
P/E n/m n/m 8.50
P/S 2.45 23.78 9.71
P/B 1.21 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.41 14.92 9.21
Earnings yield (67.88%) (159.31%) (33.15%)
Free cash flow yield (31.23%) (12.78%) (25.50%)

Profitability

Metric IPSC SRZN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (385.28%) 0.00%
Net margin 0.00% (2,887.07%) 0.00%
Free cash flow margin 0.00% (303.92%) 0.00%
Return on equity (49.65%) 387.44% (56.36%)
Return on assets (38.41%) (304.47%) (48.04%)
Return on invested capital (64.92%) 0.00% 0.00%

Growth

Metric IPSC SRZN Biotechnology median
Revenue growth (TTM) 8,286.72% (8.79%) 6.02%
EPS growth (last fiscal year) 93.12% (49.38%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPSC SRZN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.28 12.14 4.72
Net debt to EBITDA 17.95 2.15 0.96

Dividend

Metric IPSC SRZN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IPSC SRZN Biotechnology median
Market cap 271.61m 294.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack